Opening Bell Analysts Research Calls for Monday, February 27

Photo of Paul Ausick
By Paul Ausick Published
Opening Bell Analysts Research Calls for Monday, February 27

© Mario Tama / Getty Images News via Getty Images

This report was sent to Briefing.com subscribers earlier today. 

Research calls posted earlier this morning are available here.

Upgrades:

> Dyne Therapeutics (DYN) upgraded to Strong Buy from Outperform at Raymond James; tgt raised to $27

> Enphase Energy (ENPH) upgraded to Buy from Neutral at Janney; tgt $282

> Frontier Communications Parent (FYBR) upgraded to Strong Buy from Outperform at Raymond James; tgt $37

> Frontier Group Holdings (ULCC) upgraded to Outperform from Mkt Perform at Raymond James; tgt $15

> Michelin (MGDDY) upgraded to Buy from Neutral at Goldman

> Pennant Group (PNTG) upgraded to Buy from Hold at Stifel; tgt raised to $16

> Pioneer Natural Resources (PXD) upgraded to Buy from Hold at Tudor, Pickering, Holt & Co.

> Rightmove (RTMVY) upgraded to Hold from Reduce at HSBC Securities

> Universal Insurance (UVE) upgraded to Overweight from Neutral at Piper Sandler; tgt raised to $19

> Willis Towers Watson (WTW) upgraded to Buy from Neutral at Goldman; tgt $290

Downgrades:

> Amwell (AMWL) downgraded to Neutral from Overweight at Piper Sandler; tgt lowered to $3.50

> MasTec (MTZ) downgraded to Hold from Buy at Craig Hallum; tgt $97

> Nintendo (NTDOY) downgraded to Neutral from Buy at Citigroup

> Resolute Forest Products (RFP) downgraded to Sector Underperform from Sector Perform at Scotiabank; tgt raised to $22.80

> Sangamo Therapeutics (SGMO) upgraded to Outperform from Neutral at Wedbush; tgt $16

> Shell plc (SHEL) upgraded to Buy from Neutral at Goldman; tgt raised to $85

> Westlake Corporation (WLK) downgraded to Sector Perform from Outperform at RBC Capital Mkts; tgt raised to $128

> Williams Cos (WMB) downgraded to Mkt Perform from Outperform at Bernstein; tgt lowered to $34

> Wingstop (WING) downgraded to Neutral from Buy at Northcoast

Others:

> Esperion Therapeutics (ESPR) resumed with a Neutral at BofA Securities; tgt $8

> Floor & Decor (FND) removed from Tactical Underperform List at Evercore ISI

> GlaxoSmithKline (GSK) resumed with a Buy at Goldman

> Live Oak Bancshares (LOB) resumed with a Mkt Perform at Raymond James

> Option Care Health (OPCH) resumed with a Buy at Jefferies; tgt $38

> Payoneer (PAYO) initiated with a Buy at Jefferies; tgt $7

> Redfin (RDFN) initiated with a Neutral at JP Morgan; tgt $8

> RXO, Inc. (RXO) initiated with a Market Perform at Cowen; tgt $22

> U.S. Bancorp (USB) resumed with a Neutral at Goldman; tgt $51

> Woodward (WWD) initiated with an Outperform at Credit Suisse; tgt $120

> Zillow (ZG) initiated with an Overweight at JP Morgan; tgt $48

Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Top Gaining Stocks

SJM Vol: 5,284,521
APH Vol: 15,409,690
POOL Vol: 1,587,599
BLDR Vol: 3,106,921
CARR Vol: 10,221,016

Top Losing Stocks

CTRA Vol: 73,319,495
SMCI Vol: 51,854,942
GLW Vol: 16,673,394
NOW Vol: 35,824,740
ENPH Vol: 13,064,701